table of contents
When people are currently talking about the sovereignty of Europe or Germany, the buzzwords are corona vaccines, quantum computers, AI, circular economy, new materials and hydrogen. However, the corona vaccines got into this discussion by chance because we were overwhelmed by a pandemic that led us back to our most elementary need: survival.
However, the discussions about technological sovereignty are older than the vaccine problem around SARS Cov-2 and one of the technologies that have been identified as the key to independence at German and European level is almost invisible: biotechnology.
And even now – triggered by the lack of corona vaccines – biotechnology is largely reduced to a small red niche in the discussion. Red stands for one of the sectors of biotechnology, the medical one. These include drug development, biochips for medical diagnostics, personalized procedures in medicine and genetic engineering. A field in which Germany and Europe are strong, as the rapid development of vaccines from Biontech and Curevac has shown.
- Access to all heise + content
- exclusive tests, advice & background: independent, critically well-founded
- Read c’t, iX, MIT Technology Review, Mac & i, Make, c’t photography directly in your browser
- register once – read on all devices – can be canceled monthly
- first month free, thereafter € 12.95 per month
- Weekly newsletter with personal reading recommendations from the editor-in-chief
Start FREE month
Start your FREE month now
Already subscribed to heise +?
Sign up and read
Register now and read articles right away
More information about heise +
